TMS and PTSD: What the Research Shows Today
An honest, current look at the science on TMS for post-traumatic stress disorder —
and a clear explanation of what Discovery Texas Interventional Psychiatry does and
does not treat with TMS right now.
TMS at DTIP is FDA-cleared for the treatment of depressive episodes — and for decreasing
anxiety symptoms in patients with co-occurring anxiety — in adults with Major Depressive Disorder
(MDD) who have not improved with prior antidepressant treatment.
PTSD is not an FDA-cleared indication for TMS. It is not part of DTIP’s current
treatment protocol, and we do not offer TMS as a treatment for PTSD today. If you’re here because
you or someone you love is living with PTSD, we’re glad you’re looking into your options — we just
want to be upfront with you from the very first sentence of this page.
If You’re Researching PTSD Treatment, You’re Not Alone
Post-traumatic stress disorder can follow combat, an assault, an accident, childhood trauma, or
any event that overwhelmed a person’s ability to feel safe. It can show up as flashbacks,
nightmares, hypervigilance, emotional numbness, avoidance, or a nervous system that never quite
stands down. It is exhausting, and it is common — especially among veterans, first responders, and
survivors of violence or abuse.
A lot of people searching for “TMS for PTSD” are looking for something beyond medication and
talk therapy — understandably, since those don’t work equally well for everyone. That search is
reasonable, and this page exists to answer it honestly, not to sell you something we don’t
actually offer.
What the Research on TMS and PTSD Actually Shows
Researchers have been studying repetitive transcranial magnetic stimulation (rTMS) for PTSD for
more than a decade. The honest summary: the evidence is mixed, still evolving, and — as of the
most rigorous review available — not strong enough to support rTMS as an established PTSD
treatment.
A 2024 Cochrane systematic review — the gold standard for evaluating medical evidence — pooled
13 randomized controlled trials covering 577 participants. It found that active rTMS
“probably makes little to no difference to PTSD severity” immediately following
treatment compared to sham (inactive) stimulation, a conclusion the reviewers rated as
moderate-certainty evidence. A larger sensitivity analysis did show meaningful variation between
studies (heterogeneity), meaning results were not consistent from trial to trial. Reported
serious adverse events were low in both the active and sham groups, but the review rated the
evidence on safety as very low-certainty — meaning even the safety picture isn’t settled.
According to PubMed: Brown R, Cherian K, Jones K, Wickham R, Gomez R, Sahlem G. “Repetitive
transcranial magnetic stimulation for post-traumatic stress disorder in adults.” Cochrane
Database Syst Rev. 2024;8(8):CD015040.
DOI: 10.1002/14651858.CD015040.pub2
An earlier systematic review of 13 studies, published in 2021, reported that rTMS was superior
to sham stimulation for reducing both PTSD and depression severity — a more encouraging result.
But the same review explicitly rated the overall quality of that evidence as “very
low”, citing small sample sizes, inconsistent treatment protocols across studies, and
imprecise pooled results. It’s a genuine part of the research record, but it’s the kind of early,
uncertain signal that the more rigorous 2024 Cochrane review was, in part, designed to test — and
that later review found a smaller, less certain effect.
According to PubMed: Belsher BE, Beech EH, Reddy MK, Smolenski DJ, Rauch SAM, Kelber M, Issa F,
Lewis C, Bisson JI. “Advances in repetitive transcranial magnetic stimulation for posttraumatic
stress disorder: A systematic review.” J Psychiatr Res. 2021;138:598-606.
DOI: 10.1016/j.jpsychires.2021.05.011
A 2018 clinical review described rTMS for PTSD as having only “preliminary support”
from case series and open-label trials at that time, concluding that “further study is required
before rTMS can be recommended” for PTSD. The author also noted that PTSD was not, at that time,
a use of rTMS recommended by major psychiatric treatment guidelines — and that remains the case
today.
According to PubMed: Kozel FA. “Clinical Repetitive Transcranial Magnetic Stimulation for
Posttraumatic Stress Disorder, Generalized Anxiety Disorder, and Bipolar Disorder.” Psychiatr
Clin North Am. 2018;41(3):433-446.
DOI: 10.1016/j.psc.2018.04.007
The Bottom Line on the Evidence
rTMS for PTSD has not been established as effective by the highest-quality evidence available
today. It is not an FDA-cleared indication for any TMS device, including the system used at
DTIP. It is not part of DTIP’s current protocol. This is a genuinely research-stage,
investigational area of psychiatry — not something you should expect to walk in and receive as a
treatment today, here or anywhere offering TMS on-label.
If You Have PTSD and Depression
PTSD and Major Depressive Disorder frequently occur together, and this is where things get
genuinely important to understand clearly.
The distinction that matters
If you have a diagnosis of Major Depressive Disorder that has not improved with prior
antidepressant treatment — regardless of whether you also have a history of PTSD — you may be a
candidate for TMS under DTIP’s standard, FDA-cleared MDD protocol. TMS’s benefit for depression
doesn’t disappear because someone also carries a PTSD diagnosis.
But in that scenario, TMS would be offered to treat your depression, evaluated
and dosed against the MDD protocol — not offered as a treatment for your PTSD symptoms
specifically. Those are two different things, and we want you to walk away from this page
understanding the difference, not a blurred version of it.
A DTIP provider can only make that determination through a real clinical evaluation — not through
a web page. If depression is part of your picture, it’s worth a conversation.
Common Questions
Does DTIP treat PTSD with TMS?
No. DTIP’s TMS therapy is FDA-cleared for Major Depressive Disorder (including decreasing
anxiety symptoms in patients with comorbid anxiety), not for PTSD. PTSD is not currently part
of DTIP’s TMS protocol, and we do not offer TMS as a PTSD treatment.
Is TMS being studied for PTSD?
Yes, it’s an active area of research. But the most rigorous evidence to date — a 2024 Cochrane
systematic review of 13 randomized trials — found that active rTMS probably makes little to no
difference to PTSD severity compared to sham stimulation. Earlier research had shown a more
positive signal, but that earlier evidence was rated very low-certainty. In short: it’s being
studied, and the results so far are genuinely mixed rather than clearly positive.
I have PTSD and depression. Can I still get TMS?
Possibly — but for the depression, not the PTSD. If you have Major Depressive Disorder that
hasn’t responded to prior antidepressant treatment, you may qualify for TMS under DTIP’s
standard MDD protocol, whether or not you also have a PTSD history. A provider would evaluate
and treat the MDD; the PTSD itself would not be the target of TMS treatment. A clinical
evaluation is the only way to know where you stand.
What if TMS research for PTSD improves in the future?
Research in this area is ongoing, and it’s possible that future, larger, better-designed
trials could shift the picture — in either direction. If and when rTMS becomes an
FDA-cleared, evidence-supported treatment for PTSD, DTIP will evaluate whether to add it to
our protocol. We’re not going to promise a timeline or an outcome we don’t know, because
that’s not something anyone can honestly predict today.
Where can I find PTSD-focused care right now?
Trauma-focused therapies (like EMDR, Cognitive Processing Therapy, and Prolonged Exposure) and
psychiatric care remain the treatments with the strongest evidence behind them for PTSD today.
If PTSD is your primary concern, our team can talk through your history with you and, where
appropriate, point you toward trauma-focused psychiatric or therapy care — even when that
means TMS isn’t the next step.
Not Sure What’s Next? Let’s Talk.
A conversation with a DTIP provider isn’t a commitment to treatment — it’s a chance to talk
through your history, ask questions, and find out honestly whether TMS has any role in your
care, or whether you’re better served by a referral elsewhere.